Highlights and Quick Summary
- Operating Cash Flow Growth for the quarter ending June 30, 2023 was -0.8 (a -1159.87% decrease compared to previous quarter)
- Year-over-year quarterly Operating Cash Flow Growth increased by 36.04%
- Annual Operating Cash Flow Growth for 2022 was -0.29 (a -81.85% decrease from previous year)
- Annual Operating Cash Flow Growth for 2021 was -1.57 (a -46.39% decrease from previous year)
- Annual Operating Cash Flow Growth for 2020 was -2.93 (a 59.07% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Cash Flow Growth of Dyne Therapeutics, Inc.
Most recent Operating Cash Flow Growthof DYN including historical data for past 10 years.Interactive Chart of Operating Cash Flow Growth of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Operating Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.8 | 0.08 | – | – | – |
| 2022 | -0.04 | -0.59 | 0.33 | -1.76 | -0.29 |
| 2021 | -0.4 | -1.27 | -5.32 | -1.52 | -1.57 |
| 2020 | -3.99 | -0.52 | 0.84 | 0.6 | -2.93 |
| 2019 | – | – | 0.8 | 0.34 | -1.84 |
| 2018 | – | – | – | – | 0.65 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology